International Conference on Advances in Breast Cancer Treatments ICANCT on May 11-12, 2026 in Amsterdam, Netherlands

Cervical Cancer
Uterine Cancer
Vulvar Cancer
Ovarian cancer
Endometrial (Uterus) Cancer
Fallopian Tube Cancer
Gestational Trophoblastic Cancer
Gestational Trophoblastic Cancer
Vaginal Cancer
Breast Cancer in Pregnancy
Carcinogenesis
Mutagenesis
Apoptosis
Photo carcinogenesis
DNA damage
Cancer initiation and progression
Ductal adenocarcinoma
Adenocarcinoma
Biological and external factors for carcinogenesis
Metabolism of carcinogens
Anti-carcinogens
Surgery
Chemotherapy
Immunotherapy
Drug therapy, gene therapy
Stem cell transplant
Oncolytic virotherapy
Novel drug delivery system and cancer drug designing
Nanotechnology in cancer drugs
Liver cancer prognosis
Brain cancer prognosis
Squamous cell cancer prognosis
Metastatic prognosis
Functional genomics in drug discovery and development
Therapeutic antibodies and cancer vaccines
Nanotechnology in cancer drugs
Anticancer drugs in global market: economy and their cost effectiveness
Novel drug delivery system and cancer drug designing
Cancer Microenvironment
Chemo Drugs
Stealth Nanoparticles and Tumor Penetrating Peptides
Vector/Host Interaction
Early Diagnosis and Imaging
Advances in Nanotechnology
Cancer biomarker
Types of cancer biomarkers
Uses of biomarkers in cancer research
Uses of biomarkers in cancer medicine
Lung cancer biomarkers
Prostate cancer biomarkers
Breast cancer biomarkers
Advanced biomarkers for cancer
Cancer stem cells and metastatic growth
Metastatic cell growth and adhesion: Apoptosis and cell division Cancer Pathology
Cancer pathology
Metastatic cancer stem cells
Tumor immunology and immunotherapy
Tumor microenvironment and research
Tumor varieties: Benign, pre-malignant, and malignant
Tumor progression, invasion and metastasis
Radiotherapy
Observational epidemiological studies
Randomized controlled trials
Risk factors
Incidence and mortality
Infants